ATE271873T1 - Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz - Google Patents

Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz

Info

Publication number
ATE271873T1
ATE271873T1 AT98928331T AT98928331T ATE271873T1 AT E271873 T1 ATE271873 T1 AT E271873T1 AT 98928331 T AT98928331 T AT 98928331T AT 98928331 T AT98928331 T AT 98928331T AT E271873 T1 ATE271873 T1 AT E271873T1
Authority
AT
Austria
Prior art keywords
glucosamine
itch
derivatives
quick relief
localized pain
Prior art date
Application number
AT98928331T
Other languages
English (en)
Inventor
Berghe Dirk Andre Richa Vanden
Original Assignee
Bio Minerals Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8228331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE271873(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Minerals Nv filed Critical Bio Minerals Nv
Application granted granted Critical
Publication of ATE271873T1 publication Critical patent/ATE271873T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT98928331T 1997-05-21 1998-05-22 Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz ATE271873T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201513 1997-05-21
PCT/EP1998/003175 WO1998052576A1 (en) 1997-05-21 1998-05-22 Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain

Publications (1)

Publication Number Publication Date
ATE271873T1 true ATE271873T1 (de) 2004-08-15

Family

ID=8228331

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98928331T ATE271873T1 (de) 1997-05-21 1998-05-22 Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz

Country Status (8)

Country Link
US (1) US6495531B2 (de)
EP (1) EP0988040B1 (de)
AT (1) ATE271873T1 (de)
AU (1) AU8020698A (de)
DE (1) DE69825279T2 (de)
DK (1) DK0988040T3 (de)
ES (1) ES2221176T3 (de)
WO (1) WO1998052576A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
US6413525B1 (en) 1999-05-06 2002-07-02 Color Access, Inc. Methods of exfoliation using N-acetyl glucosamine
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
US6440465B1 (en) 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
DE60114724T2 (de) 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blutflussverbesserer und Mittel zur Vorbeugung oder Heilung von Thrombose
US8222232B2 (en) * 2001-02-16 2012-07-17 Cargill, Incorporated Glucosamine and N-acetylglucosamine compositions and methods of making the same fungal biomass
US7923437B2 (en) * 2001-02-16 2011-04-12 Cargill, Incorporated Water soluble β-glucan, glucosamine, and N-acetylglucosamine compositions and methods for making the same
US20020182237A1 (en) * 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
CA2408023C (en) * 2002-10-15 2012-01-03 Purepharm Inc. Glucosamine as a food and beverage additive
US20070259094A1 (en) * 2002-10-21 2007-11-08 Willem Wassenaar N-acetylglucosamine as a food and beverage additive
WO2005112948A1 (ja) * 2004-05-21 2005-12-01 Tottori University 創傷の治療又は処置のための薬剤
US20070092469A1 (en) * 2005-10-26 2007-04-26 Eric Jacobs Topically applied Glucosamine Sulfate and all its related, precursor, and derivative compounds significantly increases the skin's natural produciton of hyaluronic acid for the rejuvenation of healthier younger-looking skin; while PhosphatidylCholine is required to replace its deficiency caused by topical Dimethylaminoethanol (DMAE)
US20080188649A1 (en) * 2007-02-01 2008-08-07 Hygieia Health Co., Ltd. Method for producing glucosamine from microbial biomass
WO2012154903A1 (en) 2011-05-10 2012-11-15 Active Organics, Inc. Compositions containing extracts of mucor miehei and mucor rouxii
RU2538218C2 (ru) * 2013-03-19 2015-01-10 Открытое Акционерное Общество "Татхимфармпрепараты" Лекарственное средство для лечения остеоартрозов (варианты)
JP2019501221A (ja) * 2015-12-30 2019-01-17 アレクサンドル・ヴィレノヴィチ・アサフォフＡＳＡＦＯＶ， Ａｌｅｘａｎｄｅｒ Ｖｉｌｅｎｏｖｉｃｈ 末梢関節、脊椎関節および／または結合組織の細胞外マトリックス構成要素の処置のための製剤、製造方法および使用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
AU609090B2 (en) 1987-02-18 1991-04-26 Milor Scientific, Ltd. Composition for treatment of acne
JPH0454126A (ja) * 1990-06-21 1992-02-21 Mikio Mori 治療液及びその治療液を含有するサニタリー製品

Also Published As

Publication number Publication date
DK0988040T3 (da) 2004-11-29
EP0988040B1 (de) 2004-07-28
US20010053771A1 (en) 2001-12-20
US6495531B2 (en) 2002-12-17
EP0988040A1 (de) 2000-03-29
AU8020698A (en) 1998-12-11
WO1998052576A1 (en) 1998-11-26
DE69825279D1 (de) 2004-09-02
DE69825279T2 (de) 2005-08-04
ES2221176T3 (es) 2004-12-16

Similar Documents

Publication Publication Date Title
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
ATE271873T1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
ATE411016T1 (de) Verfahren zur prophylaxis oder behandlung von östrogen-abhängigen krankheiten
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
DE60021266D1 (de) Verwendungen von zusammensetzungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine
DE60223262D1 (de) Verwendung von fucanen in der behandlung von adhäsion, arthritis und psoriasis
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
ATE241358T1 (de) Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
DE69914726D1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
PL342078A1 (en) Inhibition of raf kinase using symmetrical and dissymmetrical substituted dimethylureas
FI972086A7 (fi) Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
ATE218854T1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin- abhängigen protein kinase
ATE138567T1 (de) Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen
ZA200004260B (en) Treatment of skin disorders.
ATE311853T1 (de) Verwendung von krillenzymen zur behandlung von zahnbelag
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
ATE214272T1 (de) Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
ATE381327T1 (de) Cethylmyristat und cetylpalmitat zurbehandlung von ekzemen und/oder psoriasis
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
DE69918972D1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
MY120530A (en) Combination preparation for use in dementia
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0988040

Country of ref document: EP